Table 1.
Presenting Characteristics
| Characteristic | N(%) or Mean (SD) |
|---|---|
| Age (yrs) | 63.6 (+-9.5) |
| Male gender | 3588 (83%) |
| Black race | 155 (3.6%) |
| Body Mass Index (kg/m2) | |
| <18.5 | 118 (2.7%) |
| >18.5 and <25.0 | 1340 (31.0%) |
| >25.0 and <30.0 | 1587 (36.7%) |
| >30.0 and <35.0 | 829 (19.2%) |
| >35.0 | 447 (10.3%) |
| Smoking History | |
| Current | 631 (14.6%) |
| Former | 2594 (60.0%) |
| Never | 1096 (25.4%) |
| Hypertension | 2500 (57.9%) |
| Diabetes Mellitus (DM) | 952 (22.0%) |
| Congestive heart failure | 103 (2.4%) |
| Coronary artery disease | 848 (19.6%) |
| Peripheral vascular disease | 202 (4.7%) |
| Renal dysfunction* | 55 (1.3%) |
| Corticosteroid use | 67 (1.6%) |
| History of Induction therapy** | 2930 (67.8%) |
| Zubrod Score | |
| 0=Normal activity, no symptoms | 936 (21.7%) |
| 1=Symptoms but fully ambulatory | 3172 (73.4%) |
| 2=Symptoms, in bed<50% of time | 185 (4.3%) |
| 3=Symptoms, in bed >50% of time | 20 (0.5%) |
| 4=Bedridden | 7 (0.2%) |
| 5=Moribund | 1 (0.02%) |
| ASA Risk Classification | |
| I | 15 (0.3%) |
| II | 667 (15.4%) |
| III | 3287 (76.1%) |
| IV | 350 (8.1%) |
| V | 2 (0.05%) |
*
History of Cr>=2 or Dialysis dependency,
**
Treatment with chemotherapy or radiotherapy within 6 mos of surgery for esophageal cancer